.
.
.
News
•
Contact
•
Careers
Login
Français
.
.
Home
The Institute
About us
History
Our legacy
Scientific Advisory Board
Our team
Annual Reports
Research Partners
Statement on Equity, Diversity and Inclusion in Research
Our Green Initiative
Working with us
Research
Our research
Principal Investigators
Recent Publications
Affiliate and Associate Members
Platforms
Histology Innovation Platform
Single Cell Imaging and Mass Cytometry Analysis Platform (SCIMAP)
McGill Platform for Cellular Pertubation (MPCP)
Metabolomics Innovation Resource (MIR)
McGill Integrated Core for Animal Modeling (MICAM)
Bioinformatics Core
Flow Cytometry
BIOBAR
Training
The Goodman experience
The Student Society
Our Programs
Financial support
Recruitment
Events
Calendar
About our events
Contribute
Overview
Ways to give
Support our researchers
Support our trainees
Your impact
Major campaign
Home
Research
Principal Investigators
Rosalind and Morris
Goodman Cancer
Institute Principal
Investigators
bouton
Filter by research areas
"
Cancer Metabolism
Tumour Microenvironment
Cancer Genome Biology
RNA Biology and Therapeutics
Early-stage Cancers
High-fatality Cancers
"
Principal Investigator Pages
Arnim
Pause
Ph.D.
Cancer energy pathways
MiTF/TFE3 transcription factors
FLCN
More
Logan
Walsh
Ph.D.
Cancer genetics
Single cell spatial technologies
Tumor microenvironment
More
Michel
Tremblay
Ph.D.
Protein tyrosine phosphatases
Cellular signaling
Immunotherapy
More
Morag
Park
Ph.D.
Receptor tyrosine kinase and proto-oncogene MET
Breast cancer and tumour microenvironment
More
Yojiro
Yamanaka
Ph.D.
Ovarian cancer
Evolution
The female reproductive tract
More
Peter
Siegel
Ph.D.
Metastasis
Metabolism
Tumour Microenvironment
More
Luke
McCaffrey
Ph.D.
Epithelial morphogenesis
Cell polarity
Early cancer progression
More
Guojun
Chen
Ph.D.
Drug delivery
Gene delivery
Cancer therapy
More
Daniela
Quail
Ph.D.
Cancer
Tumor immunology
Tumor microenvironment
More
Alain
Nepveu
Ph.D.
Transcriptional control
DNA damage response and repair pathways
Drug sensitivity and resistance
More
Josée
Dostie
Ph.D.
3D genome architecture
Epigenetics
Gene expression
More
William
Muller
Ph.D., F.R.S.C.
Breast Cancer
Lung Metastasis
Tumour Immune Microenvironment
More
Vincent
Giguere
Ph.D., F.R.S.C.
Breast cancer
Prostate cancer
Fatty liver diseases
More
Heather
Melichar
Ph.D.
T cells
Cancer immunotherapy
Autoimmunity
More
Thomas
Duchaine
Ph.D.
RNA interference (RNAi) pathways
RNA-binding proteins
Control of gene expression
More
Nahum
Sonenberg
Ph.D., F.R.S.C.
Mechanisms of mRNA translation initiation
Translational Control in Viral Infection, Cancer, Memory and Neurodegenerative Diseases
More
Ian
Watson
Ph.D.
Melanoma Translational Research
Cancer Cell Signaling
Multiomic Approaches
More
Philippe
Gros
Ph.D.
Genetic susceptibility to disease
Innate immunity
Chemotherapy resistance
More
Xiang-Jiao
Yang
Ph.D.
Molecular and epigenetic basis of cancer
Stem cells
Animal development
More
Lawrence
Kazak
Ph.D.
Metabolite signaling
Energy balance
Metabolic diseases
More
Hannah
Garner
Ph.D.
Chronic inflammation
Myeloid cell biology
Breast and ovarian cancers
More
Jose
Teodoro
Ph.D.
Tumor angiogenesis
Apoptosis and cancer
Cell signaling and cancer
More
George
Zogopoulos
M.D., Ph.D.
Pancreatic Cancer
Cancer Genetics
Translational Research
More
Sidong
Huang
Ph.D.
Functional genomics
Therapy resistance
Hard-to-treat cancers
More
Katie
Cockburn
Ph.D.
Epidermal stem cells
Cell communication
Intravital imaging
More
Discover our
research themes
Support our mission
Powered by